Cargando…

Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients

At present, immunotherapy is widely used for different mismatch repair (dMMR) or highly microsatellite instability (MSI-H) colorectal cancer patients, and tumor mutation burden (TMB) is a valuable independent predictor of response to immunotherapy. However, specific gene mutations and their relation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Linglong, Li, Yang, Gu, Haitao, Xiang, Ling, Xiong, Yongfu, Wang, Rong, Zhou, He, Wang, Jijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034916/ https://www.ncbi.nlm.nih.gov/pubmed/33714943 http://dx.doi.org/10.18632/aging.202756

Ejemplares similares

Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer
por: Xu, Zhiquan, et al.
Publicado: (2021)

Identification of a subpopulation of long-term tumor-initiating cells in colon cancer
por: Peng, Linglong, et al.
Publicado: (2020)

The critical role of peroxiredoxin-2 in colon cancer stem cells
por: Peng, Linglong, et al.
Publicado: (2021)

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma
por: Sun, Yuanyuan, et al.
Publicado: (2021)

Titin Mutation Is Associated With Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Squamous Cell Carcinoma
por: Xie, Xiaona, et al.
Publicado: (2021)

EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients
por: Zhu, Gongmin, et al.
Publicado: (2020)

Comprehensive analysis of the immune implication of FABP4 in colon adenocarcinoma
por: Wu, Dabin, et al.
Publicado: (2022)

Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma
por: Ouyang, Rong, et al.
Publicado: (2021)

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
por: Zhang, Chaohua, et al.
Publicado: (2023)

KALRN mutations promote antitumor immunity and immunotherapy response in cancer
por: Li, Mengyuan, et al.
Publicado: (2020)

Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma
por: Xu, Zhiquan, et al.
Publicado: (2022)

Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer
por: Harpaz, Noa, et al.
Publicado: (2020)

Adherence to diabetes risk reduction diet and the risk of head and neck cancer: a prospective study of 101,755 American adults
por: Wu, Xia, et al.
Publicado: (2023)

CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma
por: Li, Zhou, et al.
Publicado: (2022)

Corrigendum to “Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer”
por: Harpaz, Noa, et al.
Publicado: (2020)

circ_0038718 promotes colon cancer cell malignant progression via the miR-195-5p/Axin2 signaling axis and also effect Wnt/β-catenin signal pathway
por: Gu, Haitao, et al.
Publicado: (2021)

PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients
por: Wang, Yanni, et al.
Publicado: (2021)

Mutations in lysine methyltransferase 2C and PEG3 are associated with tumor mutation burden, prognosis, and antitumor immunity in pancreatic adenocarcinoma patients
por: Huang, Yili, et al.
Publicado: (2022)

Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data
por: Xiong, Yongfu, et al.
Publicado: (2017)

Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression‐based study
por: Xiong, Yongfu, et al.
Publicado: (2018)

Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients
por: Peng, LingLong, et al.
Publicado: (2017)

RAS Mutation in Mucinous Carcinoma of the Ovary
por: Panyavaranant, Pinyada, et al.
Publicado: (2019)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma
por: Kang, Kai, et al.
Publicado: (2020)

Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component
por: Li, Xiaodong, et al.
Publicado: (2020)

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
por: Mao, Yihao, et al.
Publicado: (2018)

The prognostic value of proliferating cell nuclear antigen expression in colorectal cancer: A meta-analysis
por: Zhou, He, et al.
Publicado: (2018)

An Exon Signature to Estimate the Tumor Mutational Burden of Right-sided Colon Cancer Patients
por: Guo, Wenbing, et al.
Publicado: (2020)

miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2021)

KRAS mutations are negatively correlated with immunity in colon cancer
por: Fu, Xiaorui, et al.
Publicado: (2020)

Correlate tumor mutation burden with immune signatures in human cancers
por: Wang, Xiaosheng, et al.
Publicado: (2019)

Prognostic Value of Tumor Mutational Burden Related to Immune Infiltration in Cervical Squamous Cell Carcinoma
por: Wen, Fang, et al.
Publicado: (2021)

Synchronous mucinous and non-mucinous lung adenocarcinomas with different epidermal growth mutational status
por: Linhas, Rita, et al.
Publicado: (2017)

Mucinous Adenocarcinoma of Colon
por: Zamir, Naima, et al.
Publicado: (2010)

Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms
por: Lee, Yi-Ju, et al.
Publicado: (2016)

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer
por: Guo, Xiong, et al.
Publicado: (2021)

Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer
por: Wang, Rong, et al.
Publicado: (2016)

Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
por: Zhou, Zhangjian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cus0b1764td1i2pbh8hu4g1v3r